We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Radiation therapy considerations during the COVID‐19 Pandemic: Literature review and expert opinions.
- Authors
Mohindra, Pranshu; Buckey, Courtney R.; Chen, Shifeng; Sio, Terence T.; Rong, Yi
- Abstract
2.F Radiotherapy care for influenza-like illness/persons under investigation/COVID-19+ patien... The challenge is exaggerated for patients who are designated to have influenza-like illness (ILI), persons under investigation (PUI) who have been tested for COVID-19 with results pending, and actual COVID-19 positive (COVID-19+) patients. A step further into the debate relates to the hypothesis of use of low-dose whole-thoracic RT as a means to limit and possibly reverse the acute respiratory distress syndrome (ARDS) that is associated with COVID-19.[[41], [43], [45]] Clinical protocols are in development to test this hypothesis in COVID-19 patients and there is a real possibility that some departments may treat noncancerous COVID-19 patients! For each individual patient, considerable time should be spent in discussing whether the treatments can be safely postponed by 1-2 months (e.g., a patient with a resected craniopharyngioma), or if alternative therapy (initiating hormonal therapy or active surveillance now for prostate cancer), or a different schedule of radiotherapy (SBRT or hypofractionated treatments) can be used, I regardless i of their COVID-19 status. Here are the possible scenarios: 3.A Continue treatment of COVID-19 positive patients, with scheduling and treatment unchanged This scenario probably has the highest risk to the other patients in the cancer center.
- Subjects
COVID-19 pandemic; WORLD Health Organization; PANDEMICS; MEDICAL personnel; CLINICS; RADIOTHERAPY; COVID-19; INTENSIVE care units
- Publication
Journal of Applied Clinical Medical Physics, 2020, Vol 21, Issue 5, p6
- ISSN
1526-9914
- Publication type
Article
- DOI
10.1002/acm2.12898